M. Marconi

发表

Comparison of anti-estrogen receptor antibodies SP1, 6F11, and 1D5 in breast cancer: lower 1D5 sensitivity but questionable clinical implications.

A. Sapino, G. Zamboni, M. Venturini, 2012, American Journal of Clinical Pathology.

Wilms’ Tumor Primary Cells Display Potent Immunoregulatory Properties on NK Cells and Macrophages

N. Tumino, I. Caruana, E. Munari, 2021, Cancers.

Progesterone Receptor Status and Clinical Outcome in Breast Cancer Patients with Estrogen Receptor-Positive Locoregional Recurrence

G. Zamboni, C. Ficorella, L. Cortesi, 2015, Tumori.

Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification.

S. Knuutila, A. Scarpa, A. Sapino, 2015, American journal of cancer research.

Expression of programmed cell death ligand 1 in non–small cell lung cancer: Comparison between cytologic smears, core biopsies, and whole sections using the SP263 assay

G. Rossi, G. Netto, M. Hoque, 2018, Cancer cytopathology.

PD‐L1 Expression Heterogeneity in Non–Small Cell Lung Cancer: Defining Criteria for Harmonization between Biopsy Specimens and Whole Sections

L. Marchionni, G. Rossi, G. Netto, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263

G. Netto, M. Hoque, G. Zamboni, 2018, Oncotarget.

PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability

G. Rossi, G. Netto, G. Zamboni, 2017, Oncotarget.

The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma

G. Zamboni, G. Tortora, J. Furlanetto, 2013, Journal of Cancer Research and Clinical Oncology.

NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.

Enrique J. deAndrés-Galiana, J. Fernández-Martínez, E. Munari, 2018, Cancer research.

Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss

G. Zamboni, M. Venturini, G. Bogina, 2011, Virchows Archiv.

PD-L1 expression in non-small cell lung cancer: evaluation of the diagnostic accuracy of a laboratory developed test using clone E1L3N in comparison with 22C3 and SP263 assays.

G. Netto, G. Zamboni, M. Brunelli, 2019, Human pathology.

PD-L1 Assays 22C3 and SP263 are Not Interchangeable in Non–Small Cell Lung Cancer When Considering Clinically Relevant Cutoffs: An Interclone Evaluation by Differently Trained Pathologists

Matteo Brunelli, Giulio Rossi, Enrico Munari, 2018, The American journal of surgical pathology.

P16 but not retinoblastoma expression is related to clinical outcome in no-special-type triple-negative breast carcinomas

G. Zamboni, M. Brunelli, G. Bogina, 2014, Modern Pathology.

Neuroendocrine differentiation in breast carcinoma: clinicopathological features and outcome

G. Zamboni, M. Brunelli, E. Munari, 2016, Histopathology.

TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study

G. Netto, G. Zamboni, N. Tumino, 2021, Modern Pathology.

Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8+ Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer

G. Rossi, G. Netto, F. Ciompi, 2021, Frontiers in Immunology.

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection

G. Netto, F. Ciompi, C. Luchini, 2022, Frontiers in Immunology.